MERCK KGAA NAM.SP.ADR (MRKC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MERCK KGAA NAM.SP.ADR (MRKC) has a cash flow conversion efficiency ratio of 0.045x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.29 Billion ≈ $1.51 Billion USD) by net assets (€28.66 Billion ≈ $33.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MRKC days of operational coverage to measure how many days the company can operate on defensive assets alone.
MERCK KGAA NAM.SP.ADR - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how MERCK KGAA NAM.SP.ADR's cash flow conversion efficiency has evolved over time, based on yearly financial data.
MERCK KGAA NAM.SP.ADR Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MERCK KGAA NAM.SP.ADR ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tourmaline Oil Corp.
TO:TOU
|
0.059x |
|
Bank of Hangzhou Co Ltd
SHG:600926
|
-0.217x |
|
Falabella
SN:FALABELLA
|
0.018x |
|
Lenovo Group Limited
F:LHL1
|
0.073x |
|
mBank SA
WAR:MBK
|
-0.739x |
|
Rongsheng Petrochemical Co Ltd
SHE:002493
|
0.167x |
|
China Shipbuilding Industry Co Ltd
SHG:601989
|
-0.021x |
|
Telkom Indonesia (Persero) Tbk PT
JK:TLKM
|
0.110x |
Annual Cash Flow Conversion Efficiency for MERCK KGAA NAM.SP.ADR (2020–2025)
The table below shows the annual cash flow conversion efficiency of MERCK KGAA NAM.SP.ADR from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see MRKC market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €28.66 Billion ≈ $33.51 Billion |
€3.93 Billion ≈ $4.60 Billion |
0.137x | -10.29% |
| 2024-12-31 | €29.99 Billion ≈ $35.06 Billion |
€4.59 Billion ≈ $5.36 Billion |
0.153x | +8.13% |
| 2023-12-31 | €26.75 Billion ≈ $31.28 Billion |
€3.78 Billion ≈ $4.42 Billion |
0.141x | -13.64% |
| 2022-12-31 | €26.00 Billion ≈ $30.40 Billion |
€4.26 Billion ≈ $4.98 Billion |
0.164x | -24.02% |
| 2021-12-31 | €21.42 Billion ≈ $25.04 Billion |
€4.62 Billion ≈ $5.40 Billion |
0.216x | +5.49% |
| 2020-12-31 | €17.02 Billion ≈ $19.89 Billion |
€3.48 Billion ≈ $4.06 Billion |
0.204x | -- |
About MERCK KGAA NAM.SP.ADR
Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more